Self-administered Parenteral Market

Future Market Insights

Key Insight

The self-administered parenteral market is projected to grow from USD 26,556.0 million in 2025 to USD 42,440.0 million by 2035, at a CAGR of 4.8%. Pre-Filled Syringes will dominate with a 42.7% market share, while diabetes will lead the application segment with a 36.4% share.

October 07, 2025

Anurag Sharma

392 Pages

Cite this Report

Self-administered Parenteral Market

https://www.futuremarketinsights.com/reports/self-administered-parenteral-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Phillips-Medisize Corporation
Solteam Group
Stevanato Group
Ypsomed AG

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Self-administered Parenteral Market

Key Players

Similar Industry Reports